The Performance of Multi-tracer Multimodality PET in Lymphoma

Status Recruiting

Clinical Trial Summary

Investigating the performance of Multi-tracer Multimodality PET in lymphoma

Clinical Trial Description

In this study investigators evaluated Nodal and Extranodal Lymphoma Lesions uptake by different molecular probe such as FDG, FAPI-04 via multimodality PET (PET/CT and PET/MR). Our Previous studies have shown that uptake of FAPI-04 on PET may be an indicator of lymphoma lesions. The combination of PET with CT/MR allows for depicting metabolic, functional and morphological properties of tumor lesions at the same time, which is therefore an alternative attractive pairing for diagnosis, staging and prognosis of lymphoma. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05004961
Study type	Observational
Source	Peking University Cancer Hospital & Institute
Contact	Xuejuan Wang, MD
Phone	86 010 88196363
Email	xuejuan_wang@hotmail.com
Status	Recruiting
Phase
Start date	September 15, 2019
Completion date	December 31, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04555642` - Early Diagnosis of Therapy-associated Cardiotoxicity Basing on Multi-tracer Multimodality PET/MRI
Recruiting	`NCT05188872` - Application of 68Ga-Pentixafor PET/CT in Primary Aldosteronism and Pre-postoperative of SAAE	N/A
Recruiting	`NCT04983095` - Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer	Phase 3
Recruiting	`NCT05610098` - Gene Expression Profiles in Spinal Tuberculosis.
Recruiting	`NCT04416165` - Comparison of FDG and FAPI in Patients With Various Types of Cancer	N/A
Recruiting	`NCT04750772` - Positron Nuclide Labeled DOTA-FAPI PET Study in Colocrectal Cancer	N/A
Recruiting	`NCT04831541` - 68Ga-PSMA-11 PET/CT in Patients With Various Types of Cancer	Early Phase 1
Recruiting	`NCT06017973` - The Role of Imaging in the Diagnosis, Management and Prognosis of Possible Non-convulsive Status Epilepticus	N/A
Recruiting	`NCT06188468` - ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Solid Tumors	N/A
Recruiting	`NCT03830242` - Diagnostic Significance of FDG PET/CT Dynamic Imaging in Detecting Metastatic Lymph Nodes With Papillary Thyroid Cancer.	N/A
Recruiting	`NCT06387381` - 68Ga-PSFA PET Imaging in Patients With PSMA/FAP Positive Disease	Early Phase 1
Recruiting	`NCT05506566` - 68Ga-FAP-CHX PET/CT : Dosimetry and Preliminary Clinical Translational Studies	Phase 1/Phase 2
Not yet recruiting	`NCT04367948` - Positron Nuclide Labeled NOTA-FAPI PET Study in Lymphoma	N/A
Recruiting	`NCT05757804` - Study of 18F-0502B PET Imaging Targeting α-synuclein in the Diagnosis of α-synuclein-related Diseases
Completed	`NCT05392205` - Comaprison of 68Ga-FAP-2286 and 18F-FDG PET/CT in Patients With Various Types of Cancer	N/A
Completed	`NCT03741231` - 18FDG-PET in Patients With Melanoma or NSCLC Treated With Immunotherapy
Completed	`NCT01035164` - Evaluation of ZK 6032924 in Probable Alzheimer's Disease Patients Versus Healthy Volunteers and the Radiation Dosimetry of ZK 6032924 in Healthy Volunteers	Phase 1
Completed	`NCT03107663` - ⁸⁹Zr-Df-IAB22M2C PET/CT in Patients With Selected Solid Malignancies or Hodgkin's Lymphoma	Phase 1
Recruiting	`NCT03636607` - Diagnostic Significance of Single Center, Open and Prospective Evaluation of <Sup>18<Sup>F-FDG PET/CT Dynamic Imaging and Genomic Sequencing in Detecting Metastatic Lesions of Primary Hepatocellular Carcinoma	N/A
Recruiting	`NCT06465017` - ImmunoPET Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) in Thyroid Cancer	N/A